The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Chimeric Nucleases Stimulate Gene Targeting in Human Cells
Abstract
Correction of gene defects in human somatic cells by targeting as has been used in murine embryonic stem cells (1, 2) has been precluded by the low spontaneous rate of gene targeting (3). However, creation of a DNA double-stranded break (DSB) in the genomic target (DSB-GT) can stimulate homologous recombination by over 1000-fold (4). \n \nWe can rapidly and quantitatively measure gene targeting by correcting a mutation in a green fluorescent protein (GFP) gene that has been stably integrated into the genome (5) (fig. S1). With an optimized GFP gene targeting system, the introduction of a DSB by I–Sce I (Sce) stimulated GT >40,000-fold and the absolute rate of gene targeting reached 3 to 5% (fig. S2). Such a system, however, depends on the prior introduction of a Sce binding site into the target gene and cannot be used for endogenous genes. Chimeric nucleases (CNs) have the potential to create sequence-specific DSBs (6). CNs—fusions between zinc finger binding DNA binding domains and the endonuclease domain of Fok I—can sitespecifically cleave naked DNA in vitro (6), extrachromosomal DNA in Xenopus oocytes (7), and chromosomal DNA in Drosophila (8). CNs work as dimers, and their efficiency depends on the spacing and orientation of the zinc finger binding sites with respect to the length of the amino acid linker between the DNA binding and endonuclease domains (7, 9). \n \nQQR is an artificial zinc finger DNA binding domain that recognizes the sequence 5′-GGGGAAGAA-3′ with nanomolar affinity (10). We modified QQR chimeric nucleases (QQR-CNs) (7, 9) (Fig. 1A) and tested whether they stimulated gene targeting (Fig. 1B). The background rate of gene targeting was 0.71 events per million transfected cells (fig. S1C). QQRL18-CN stimulated gene targeting 17-fold on target QQR6 and 260-fold on target QQR8 (Fig. 1B). QQRL0-CN did not stimulate gene targeting on target QQR8, but it was as efficient as Sce in stimulating gene targeting by over 2000-fold on target QQR6 (Fig. 1B). QQRL18-CN showed some preference for an 8–base pair (bp) spacing between binding sites whereas QQRL0-CN preferred 6-bp spacing. Thus, removing the linker between the zinc spacfinger and the nuclease domains increased the activity and specificity of the fusion protein in mammalian cells. As controls, we showed that the CNs did not stimulate gene targeting if (i) they lacked a nuclear localization signal, (ii) there was a single binding site rather than an inverted repeat binding site in the target, and (iii) the cognate binding site was changed. Thus, homodimers of CNs are potent stimulators of gene targeting in human somatic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, if the nuclease action mutates unintended targets that are important for cellular physiology, the treated cells may become dysfunctional or even die [61,62,63].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [62]
In the citing paper
“The fundamental safety concern for using ZFN mediated gene disruption for human therapy is the specificity of gene targeting.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [62]
Citations
Cites
Altering the Genome by Homologous Recombination
Capecchi, M. R. (1989) · Science · doi:10.1126/science.2660260 · Cited by 2,037
DNA Recognition by Cys2His2 Zinc Finger Proteins
Wolfe, S. A., Nekludova, L., & Pabo, C. O. (2000) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.29.1.183 · Cited by 1,053
Targeted Chromosomal Cleavage and Mutagenesis in Drosophila Using Zinc-Finger Nucleases
Bibikova, M., Golic, M., Golic, K. G., & Carroll, D. (2002) · Genetics · doi:10.1093/genetics/161.3.1169 · Cited by 860
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells
Doetschman, T., Gregg, R., Maeda, N., Hooper, M., Melton, D., Thompson, S., & Smithies, O. (1987) · Nature · doi:10.1038/330576a0 · Cited by 756
Stimulation of Homologous Recombination through Targeted Cleavage by Chimeric Nucleases
Bibikova, M. V., Carroll, D., Segal, D. J., Trautman, J. K., Smith, J., Kim, Y., & Chandrasegaran, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.289-297.2001 · Cited by 614
Smith, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.17.3361 · Cited by 425
Genetic manipulation of genomes with rare-cutting endonucleases
Jasin, M. (1996) · Trends in Genetics · doi:10.1016/0168-9525(96)10019-6 · Cited by 391
Positive genetic selection for gene disruption in mammalian cells by homologous recombination.
Sedivy, J. M., & Sharp, P. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.227 · Cited by 119
Specific DNA-RNA Hybrid Binding by Zinc Finger Proteins
Shi, Y., & Berg, J. M. (1995) · Science · doi:10.1126/science.7536342 · Cited by 86
Chimeric Restriction Enzymes: What Is Next?
Chandrasegaran, S., & Smith, J. (1999) · Biological Chemistry · doi:10.1515/bc.1999.103 · Cited by 85
Flagged first, then by citations
Research works printed but not linked: 1
- S. Chandrasegaran, J. Smith, Biol. Chem.380, 841 (1999).
Cited by
Sorted by citations
Items 701–740 of 740
Gene therapy for primary immune deficiencies
Kohn, D. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00058-2
Homanics, G. E. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.4951957.4884055
Introducing Point Mutations into Human Pluripotent Stem Cells Using Seamless Genome Editing
Wang, Y., Smith, A. J. H., & Hay, D. C. (2020) · Journal of Visualized Experiments · doi:10.3791/61152-v
Generation of Knock-In Mouse by Genome Editing
Fujii, W. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3016-7_8
Therapeutics and Diagnostics Discovery
Mochly‐Rosen, D., Grimes, K., Hannoush, R. N., Koch, B., Ehrenkaufer, G. M., Erlanson, D. A., Saiki, J., Wilson, J. L., Aldred, S. F., Garcia, A. A., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-34724-5_2
Letsou, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822563-9.00095-0
Genome Editing Technologies and Application in Medicine: Discoveries, Challenges, and Prospects
Lohrasbi, R., & Amiri‐Yekta, A. (2023) · Cell and Tissue Journal · doi:10.61186/jct.14.3.241
Genome Editing in Bacillus Licheniformis: Current Approaches and Applications
Raphel, S., & Halami, P. M. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815165678124010011
How Gene Editing Is Changing Drug Development
Xu, J., Yoder, L., & Yang, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85704-8.00032-3
A Story of Perseverance: An Interview with Matthew Porteus
Davies, K., & Porteus, M. H. (2024) · GEN Edge · doi:10.1089/genedge.6.01.112
Self-citationGene Therapy for Hypophosphatasia: Current Management and Future
Matsumoto, T., Narisawa, S., Millán, P. J. L., & Miyake, K. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006268 · Cited by 2
Du, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23865-9.00002-2
Wang, H., Zhao, R., Zhang, B., Xiao, Y., Yu, C., Wang, Y., Yu, C., Tang, Y., Li, Y., Lu, B., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202423473
Functional Toxicology: Key Concepts and Applications
Kim, C. H., & Vulpe, C. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00248-5
Wang, Y., Hu, J., & Zhang, J. (2025) · Journal of Visualized Experiments · doi:10.3791/67508
Zhang, Y., Hao, F., Gao, Y., Song, W., Su, C., Guo, X., & Liu, D. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01679-x
Genome Editing and Human-Induced Pluripotent Stem Cells Facilitate Parkinson’s Disease Modeling
Polanco, C. M., Inzunza, J., Nalvarte, I., & Arias, J. (2025) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-031-94101-6_3
Xie, H., Linning‐Duffy, K., Demireva, E. Y., Toh, H., Abolibdeh, B., Shi, J., Zhou, B., Iwase, S., & Yan, L. (2024) · Figshare · doi:10.6084/m9.figshare.26741621
Advancements in the treatment of Congenital Heart Disease
Aggarwal, H. (2023) · Journal of High School Science · doi:10.64336/001c.77770
Xie, H., Linning‐Duffy, K., Demireva, E. Y., Toh, H., Abolibdeh, B., Shi, J., Zhou, B., Iwase, S., & Yan, L. (2024) · Figshare · doi:10.6084/m9.figshare.26157142
Xie, H., Linning‐Duffy, K., Demireva, E. Y., Toh, H., Abolibdeh, B., Shi, J., Zhou, B., Iwase, S., & Yan, L. (2024) · Figshare · doi:10.6084/m9.figshare.26157552
Edmondson, C., Zhou, Q., & Liu, X. (2021) · Figshare · doi:10.6084/m9.figshare.15063997
Oh, D., Seok, C., Park, H. W., Park, S., Lee, J., Choi, H., Jawad, A., Ham, J., Jang, H., Lee, S. C., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-28385-9
Development of a functional assay for CHD7, a protein involved in CHARGE syndrome
Brajadenta, G. S. (2019) · theses.fr (ABES) · doi:10.70675/4fbb6e82ze10az420czadafze974d3fb997c
Génotoxicité des systèmes CRISPR-Cas9.
Cullot, G. (2019) · theses.fr (ABES) · doi:10.70675/cb1809e4zaafbz4fc1z89e9zeb0e5fd69275
Gene editing approaches of microsatellite disorders : shortening expanded repeats
Poggi, L. (2020) · theses.fr (ABES) · doi:10.70675/741f0470z28a0z4c3bz9e75ze578bdc49074 · Cited by 1
Mécanismes de réparations d’une cassure double-brin et résection au sein d’un microsatellite humain
Vaysse-Zinkhöfer, W. (2021) · theses.fr (ABES) · doi:10.70675/315e7956zf006z4518z99adz6282679fa7af
Stambolsky, D. V., Zakharova, A. V., & Karagyaur, M. N. (2026) · Регенерация органов и тканей. · doi:10.60043/2949-5938-2025-1-10-21
Harnessing host microbiome co-metabolism system (HMMS) for new drug discovery
Hou, Y., & Zeng, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-31402-5.00002-5
Sorghum Genomics for Nutritional Traits Improvement
Hanamaratti, N. G., Reddy, S. E., Karthik, R., Shailaja, D. S., Gaganashree, K. P., & Marigoudar, R. (2026) · Sustainability Sciences in Asia and Africa · doi:10.1007/978-981-95-9827-4_4
Gene Therapy Approaches for the Treatment of Phenylketonuria
Martinez, M. A., Young, L. J., Harding, C. O., Schwank, G., & Thöny, B. (2026) · Springer eBooks · doi:10.1007/978-3-032-26690-3_20
A brief history of gene therapy for ornithine transcarbamylase deficiency
Breilyn, M. S., Konczal, L. L., & Harding, C. O. (2026) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2026.110257
Using Zinc Finger Nucleases for Targeted Genome Modification in the Zebrafish
McCammon, J. M. (2010) · eScholarship (California Digital Library)
Metadata
- Authors
- Porteus, M. H., & Baltimore, D.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- Porteus, Matthew H.
- Baltimore, David
- Venue
- Science
- Published
- 2003-05-02
- Volume
- 300
- Issue
- 5620
- Pages
- 763-763
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2051395442
- Cited by
- 741
- References
- 10
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 25 · 2023: 16 · 2022: 26 · 2021: 30 · 2020: 34 · 2019: 33 · 2018: 27 · 2017: 28 · 2016: 52 · 2015: 45 · 2014: 69 · 2013: 41 · 2012: 51
- FWCI
- 9.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM039458, R01 GM39458)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- gene targeting, homologous recombination, zinc finger DNA-binding domain, DNA double-strand breaks, linker length, somatic cell therapy, gene therapy vectors, somatic cell hybrids, somatic cell nuclear transfer
- MeSH terms
- Cell Line, DNA, Humans, Luminescent Proteins, Mutation, Recombinant Fusion Proteins, Recombination, Genetic, Transfection, Deoxyribonucleases, Type II Site-Specific, Zinc Fingers, Gene Targeting, Dimerization, Nuclear Localization Signals, Saccharomyces cerevisiae Proteins, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review